231 related articles for article (PubMed ID: 31994476)
1. Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.
O'Neill A; Wilson R; Blest-Hopley G; Annibale L; Colizzi M; Brammer M; Giampietro V; Bhattacharyya S
Psychol Med; 2021 Mar; 51(4):596-606. PubMed ID: 31994476
[TBL] [Abstract][Full Text] [Related]
2. Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial.
Bhattacharyya S; Wilson R; Appiah-Kusi E; O'Neill A; Brammer M; Perez J; Murray R; Allen P; Bossong MG; McGuire P
JAMA Psychiatry; 2018 Nov; 75(11):1107-1117. PubMed ID: 30167644
[TBL] [Abstract][Full Text] [Related]
3. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.
Bhattacharyya S; Fusar-Poli P; Borgwardt S; Martin-Santos R; Nosarti C; O'Carroll C; Allen P; Seal ML; Fletcher PC; Crippa JA; Giampietro V; Mechelli A; Atakan Z; McGuire P
Arch Gen Psychiatry; 2009 Apr; 66(4):442-51. PubMed ID: 19349314
[TBL] [Abstract][Full Text] [Related]
4. Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.
Bhattacharyya S; Crippa JA; Allen P; Martin-Santos R; Borgwardt S; Fusar-Poli P; Rubia K; Kambeitz J; O'Carroll C; Seal ML; Giampietro V; Brammer M; Zuardi AW; Atakan Z; McGuire PK
Arch Gen Psychiatry; 2012 Jan; 69(1):27-36. PubMed ID: 22213786
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid modulation of functional connectivity within regions processing attentional salience.
Bhattacharyya S; Falkenberg I; Martin-Santos R; Atakan Z; Crippa JA; Giampietro V; Brammer M; McGuire P
Neuropsychopharmacology; 2015 May; 40(6):1343-52. PubMed ID: 25249057
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol attenuates insular activity during motivational salience processing in patients with early psychosis.
Gunasekera B; Wilson R; O'Neill A; Blest-Hopley G; O'Daly O; Bhattacharyya S
Psychol Med; 2023 Jul; 53(10):4732-4741. PubMed ID: 35775365
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol modulation of hippocampal glutamate in early psychosis.
O'Neill A; Annibale L; Blest-Hopley G; Wilson R; Giampietro V; Bhattacharyya S
J Psychopharmacol; 2021 Jul; 35(7):814-822. PubMed ID: 33860709
[TBL] [Abstract][Full Text] [Related]
8. The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study.
Bloomfield MAP; Green SF; Hindocha C; Yamamori Y; Yim JLL; Jones APM; Walker HR; Tokarczuk P; Statton B; Howes OD; Curran HV; Freeman TP
J Psychopharmacol; 2020 Sep; 34(9):981-989. PubMed ID: 32762272
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of the antipsychotic properties of cannabidiol in humans.
Iseger TA; Bossong MG
Schizophr Res; 2015 Mar; 162(1-3):153-61. PubMed ID: 25667194
[TBL] [Abstract][Full Text] [Related]
10. A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis.
Davies C; Wilson R; Appiah-Kusi E; Blest-Hopley G; Brammer M; Perez J; Murray RM; Allen P; Bossong MG; McGuire P; Bhattacharyya S
Transl Psychiatry; 2020 Sep; 10(1):311. PubMed ID: 32921794
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia.
Sarpal DK; Robinson DG; Lencz T; Argyelan M; Ikuta T; Karlsgodt K; Gallego JA; Kane JM; Szeszko PR; Malhotra AK
JAMA Psychiatry; 2015 Jan; 72(1):5-13. PubMed ID: 25372846
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Bhattacharyya S; Morrison PD; Fusar-Poli P; Martin-Santos R; Borgwardt S; Winton-Brown T; Nosarti C; O' Carroll CM; Seal M; Allen P; Mehta MA; Stone JM; Tunstall N; Giampietro V; Kapur S; Murray RM; Zuardi AW; Crippa JA; Atakan Z; McGuire PK
Neuropsychopharmacology; 2010 Feb; 35(3):764-74. PubMed ID: 19924114
[TBL] [Abstract][Full Text] [Related]
13. fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy.
Allendorfer JB; Nenert R; Bebin EM; Gaston TE; Grayson LE; Hernando KA; Houston JT; Hansen B; Szaflarski JP
Epilepsy Behav; 2019 Jul; 96():114-121. PubMed ID: 31129526
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I:C) model of neurodevelopmental disorders.
Osborne AL; Solowij N; Babic I; Lum JS; Huang XF; Newell KA; Weston-Green K
Brain Behav Immun; 2019 Oct; 81():574-587. PubMed ID: 31326506
[TBL] [Abstract][Full Text] [Related]
15. The impact of cannabidiol treatment on resting state functional connectivity, prefrontal metabolite levels and reward processing in recent-onset patients with a psychotic disorder.
van Boxel R; Gangadin SS; Janssen H; van der Steur S; van der Vinne LJC; Dortants L; Pelgrim TAD; Draisma LWR; Tuura R; van der Meer P; Batalla A; Bossong MG
J Psychiatr Res; 2023 Jul; 163():93-101. PubMed ID: 37207437
[TBL] [Abstract][Full Text] [Related]
16. Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity.
Grimm O; Löffler M; Kamping S; Hartmann A; Rohleder C; Leweke M; Flor H
Eur Neuropsychopharmacol; 2018 Jul; 28(7):841-849. PubMed ID: 29887287
[TBL] [Abstract][Full Text] [Related]
17. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV
J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455
[TBL] [Abstract][Full Text] [Related]
18. The effect of cannabidiol (CBD) on low-frequency activity and functional connectivity in the brain of adults with and without autism spectrum disorder (ASD).
Pretzsch CM; Voinescu B; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Williams S; Murphy DG; Daly E; McAlonan GM
J Psychopharmacol; 2019 Sep; 33(9):1141-1148. PubMed ID: 31237191
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial.
Dixon T; Cadenhead KS
Trials; 2023 Nov; 24(1):775. PubMed ID: 38037108
[TBL] [Abstract][Full Text] [Related]
20. Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report.
Davies C; Appiah-Kusi E; Wilson R; Blest-Hopley G; Bossong MG; Valmaggia L; Brammer M; Perez J; Allen P; Murray RM; McGuire P; Bhattacharyya S
Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):461-475. PubMed ID: 34480630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]